Your browser doesn't support javascript.
loading
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis.
Piedra, Katrina; Peterson, Tim; Tan, Carlyn; Orozco, Jennifer; Hultcrantz, Malin; Hassoun, Hani; Mailankody, Sham; Lesokhin, Alexander; Shah, Urvi; Lu, Sydney; Patel, Dhwani; Derkach, Andriy; Wilkins, Cy R; Korde, Neha.
Afiliación
  • Piedra K; Department of Pharmacy, Sylvester Comprehensive Cancer Center, University of Miami Hospitals and Clinics, Miami, FL, USA.
  • Peterson T; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tan C; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Orozco J; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Hultcrantz M; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hassoun H; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mailankody S; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Lesokhin A; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Shah U; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Lu S; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Patel D; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Derkach A; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wilkins CR; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Korde N; Multiple Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Br J Haematol ; 196(1): 105-109, 2022 01.
Article en En | MEDLINE | ID: mdl-34396516
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Tromboembolia Venosa / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Tromboembolia Venosa / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos